These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18789710)

  • 41. Analytical validation of accelerator mass spectrometry for pharmaceutical development.
    Keck BD; Ognibene T; Vogel JS
    Bioanalysis; 2010 Mar; 2(3):469-85. PubMed ID: 21083256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accelerator mass spectrometry in pharmaceutical research and development--a new ultrasensitive analytical method for isotope measurement.
    Garner RC
    Curr Drug Metab; 2000 Sep; 1(2):205-13. PubMed ID: 11465084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Chemical ionization mass spectrometry and its use in the pharmacological field].
    Belvedere G; Frigerio A; Pantarotto C; Zanol M
    Boll Chim Farm; 1976 Jun; 115(6):419-31. PubMed ID: 1008947
    [No Abstract]   [Full Text] [Related]  

  • 44. The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences.
    Becker JS; Jakubowski N
    Chem Soc Rev; 2009 Jul; 38(7):1969-83. PubMed ID: 19551177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of drugs by chemical ionization mass spectroscopy. II.
    Saferstein R; Chao JM; Manura J
    J Forensic Sci; 1974 Jul; 19(3):463-85. PubMed ID: 4852342
    [No Abstract]   [Full Text] [Related]  

  • 46. Mass spectrometry imaging in drug development.
    Nilsson A; Goodwin RJ; Shariatgorji M; Vallianatou T; Webborn PJ; Andrén PE
    Anal Chem; 2015 Feb; 87(3):1437-55. PubMed ID: 25526173
    [No Abstract]   [Full Text] [Related]  

  • 47. Quantification of small molecules in plasma with direct analysis in real time tandem mass spectrometry, without sample preparation and liquid chromatographic separation.
    Zhao Y; Lam M; Wu D; Mak R
    Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3217-24. PubMed ID: 18803333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An accurate-mass-based spectral-averaging isotope-pattern-filtering algorithm for extraction of drug metabolites possessing a distinct isotope pattern from LC-MS data.
    Zhu P; Tong W; Alton K; Chowdhury S
    Anal Chem; 2009 Jul; 81(14):5910-7. PubMed ID: 19518135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sample collection, biobanking, and analysis.
    Ahsman MJ; Tibboel D; Mathot RA; de Wildt SN
    Handb Exp Pharmacol; 2011; 205():203-17. PubMed ID: 21882113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological and biomedical (14)C-accelerator mass spectrometry and graphitization of carbonaceous samples.
    Chung IM; Kim SH
    Analyst; 2013 Jun; 138(12):3347-55. PubMed ID: 23626987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pulsed supersonic beams with nucleobases.
    Sarfraz A; Rademann K; Christen W
    Anal Bioanal Chem; 2012 Oct; 404(6-7):2087-90. PubMed ID: 22895738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tandem mass spectrometry: the competitive edge for pharmacology.
    Fenselau C
    Annu Rev Pharmacol Toxicol; 1992; 32():555-78. PubMed ID: 1605578
    [No Abstract]   [Full Text] [Related]  

  • 53. High-speed liquid chromatography/tandem mass spectrometry for the determination of drugs in biological samples.
    Covey TR; Lee ED; Henion JD
    Anal Chem; 1986 Oct; 58(12):2453-60. PubMed ID: 3789400
    [No Abstract]   [Full Text] [Related]  

  • 54. Environmental mass spectrometry: emerging contaminants and current issues.
    Richardson SD
    Anal Chem; 2004 Jun; 76(12):3337-63. PubMed ID: 15193112
    [No Abstract]   [Full Text] [Related]  

  • 55. Accelerator mass spectrometry for measuring low-dose carcinogen binding to DNA.
    Felton JS; Turteltaub KW
    Environ Health Perspect; 1994 May; 102(5):450-2. PubMed ID: 8593847
    [No Abstract]   [Full Text] [Related]  

  • 56. Environmental mass spectrometry: emerging contaminants and current issues.
    Richardson SD
    Anal Chem; 2008 Jun; 80(12):4373-402. PubMed ID: 18498180
    [No Abstract]   [Full Text] [Related]  

  • 57. Purification of drugs from biological fluids by counter-current chromatography.
    Hochlowski JE; Pan JY; Searle PA; Buck WR; Spanton SG
    J Chromatogr A; 2009 Aug; 1216(34):6162-9. PubMed ID: 19589529
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can we use the CO2 concentrations determined by continuous-flow isotope ratio mass spectrometry from small samples for the Keeling plot approach?
    Joos O; Saurer M; Heim A; Hagedorn F; Schmidt MW; Siegwolf RT
    Rapid Commun Mass Spectrom; 2008 Dec; 22(24):4029-34. PubMed ID: 19009520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcium isolation from large-volume human urine samples for 41Ca analysis by accelerator mass spectrometry.
    Miller JJ; Hui SK; Jackson GS; Clark SP; Einstein J; Weaver CM; Bhattacharyya MH
    Appl Radiat Isot; 2013 Aug; 78():57-61. PubMed ID: 23672965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coupling ultra high-pressure liquid chromatography with single quadrupole mass spectrometry for the analysis of a complex drug mixture.
    Schappler J; Nicoli R; Nguyen D; Rudaz S; Veuthey JL; Guillarme D
    Talanta; 2009 Apr; 78(2):377-87. PubMed ID: 19203598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.